ExcepGen is a startup based in the United States, 2 tracked investors.
ExcepGen is a company headquartered in the United States. Brouky records 2 investors associated with the company.
ExcepGen develops RNA-based medicines that improve tolerability by modulating the innate immune response to nucleic acid vaccines using their RNAx platform technology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.